跳至主要内容
临床试验/ACTRN12618000931279
ACTRN12618000931279招募中未知

Assessing Predictive and Prognostic Biomarkers in Germ Cell Tumours - Testis

Walter and Eliza Hall Institute for Medical Research0 个研究点目标入组 800 人开始时间: 2018年6月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
800

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Male

入选标准

  • Histologically or cytologically confirmed GCT (non-seminoma or seminoma); or exceptionally raised tumour markers (AFP greater than or equal to 1000ng/mL and/or HCG greater than or equal to 5000 IU/L) without histologic or cytologic confirmation in the rare case where pattern of metastases consistent with GCT, high tumour burden, and a need to start therapy urgently.
  • Primary arising in testis, retro-peritoneum, or mediastinum.
  • Able to be accessible for follow-up and data collection.
  • Written, voluntary and informed consent.
  • Able to undergo collection of blood specimens.

排除标准

  • No archival tissue specimen available.
  • Patient not accessible for follow up and data collection.

研究者

发起方
Walter and Eliza Hall Institute for Medical Research

相似试验